Search results
Results from the WOW.Com Content Network
Hepatitis E is inflammation of the liver caused by infection with the hepatitis E virus (HEV); [4] [5] it is a type of viral hepatitis. [6] Hepatitis E has mainly a fecal-oral transmission route that is similar to hepatitis A , although the viruses are unrelated.
Hepatitis A and hepatitis B can be prevented by vaccination. Effective treatments for hepatitis C are available but costly. [6] In 2013, about 1.5 million people died from viral hepatitis, most commonly due to hepatitis B and C. [6] East Asia, in particular Mongolia, is the region most affected. [6]
Hepatitis E virus. Similar to hepatitis A, treatment of hepatitis E is supportive and includes rest and ensuring adequate nutrition and hydration. [115] Hospitalization may be required for particularly severe cases or for pregnant women. [115]
Hepatitis C virus: Hepatitis C: Blood testing for antibodies or viral RNA: Antivirals (sofosbuvir, simeprevir, others) Under research [17] Hepatitis D Virus: Hepatitis D: Immunoglobulin G Antivirals, pegylated interferon alpha No Hepatitis E virus: Hepatitis E: Hepatitis E virus (HEV) Rest, ribavirin (if chronic) Yes: Herpes simplex virus 1 and ...
In all cases, after just 12 weeks of treatment, 95 percent of people diagnosed with hepatitis C are cured. How to Prevent Hepatitis C Cured of hepatitis C, however, doesn’t mean immune.
Hepatitis E virus (HEV) is the causative agent of hepatitis E. [2] [3] Globally, approximately 939 million corresponding to 1 in 8 individuals have ever experienced HEV infection. About 15–110 million individuals have recent or ongoing HEV infection. [4] The virus particle was first seen in 1983, [5] but was only molecularly cloned in 1989. [6]
Medicare Part D covers hepatitis C treatments. However, people with hepatitis C who seek treatment with direct-acting antivirals may still be responsible for significant costs, as these are ...
Without treatment, the ten-year survival rate for individuals with symptomatic autoimmune hepatitis is 50%. However, with treatment, the ten-year survival rate is above 90%. Despite the benefits of treatment, people with autoimmune hepatitis generally have a lower transplant-free survival than the general population.